<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-87128</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prognostic value of inflammatory markers and lipid profile in patients suffering from intermittent claudication &#150; a pilot study</dc:title>
<dc:description xml:lang="en">Background and objective: To analyse clinical and serological variables (lipid profile, inflammatory biomarkers) as potential risk factors for the development of short-term cardiovascular events and mortality in patients suffering from intermittent claudication. Patients and methods: We included all patients with a first-time diagnosis of vascular intermittent claudication in our center during 2005-2006. We analysed clinical data, serological parameters (creatinine, total cholesterol, LDL-cholesterol, HDL-cholesterol, ApolipoproteinA1, ApolipoproteinB100, lipoprotein(a), homocysteine, C-reactive protein, erythrocyte sedimentation rate [ESR], fibrinogen), cardiovascular events and mortality during 1-3 year follow-up.Results: We included 162 patients: 143 (88.3%) men, mean (SD) age 66 (10.4) (41-86) years, 76 (46.9%) active smokers, 96 (59.3%) hypertensive, 56 (34.6%) diabetic, 129 (79.6%) hypercholesterolemic. We registered 16 (9.9%) coronary/cerebrovascular events, 18 (11.1%) lower limb vascular events and 9 (5.9%) late deaths during follow-up (mean [SD] 18.2 [8] months). Hypertension was the only predictor of coronary or cerebrovascular events (p=0.013); heart disease and HDL-cholesterol&lt;45mg/dL were independent risk factors for lower limb vascular events (p=0.021 and 0.049), and ESR&gt;20mm/h was associated with all-cause death (p=0.008). Conclusions: Reduced HDL-cholesterol and elevated ESR have emerged as independent risk factors for short-term lower limb vascular events and death</dc:description>
<dc:creator>Vega de Céniga, Melina</dc:creator>
<dc:creator>Izagirre, Maite</dc:creator>
<dc:creator>Barba, Ángel</dc:creator>
<dc:creator>Bravo, Esther</dc:creator>
<dc:creator>Estallo, Luis</dc:creator>
<dc:creator>Esteban Salan, Margarita</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo: Analizar variables clínicas y serológicas (perfil lipídico, marcadores inflamatorios) como potenciales factores de riesgo para el desarrollo de eventos cardiovasculares y mortalidad a corto plazo en pacientes con claudicación intermitente. Pacientes y método: Incluimos todos los pacientes con diagnóstico inicial de claudicación intermitente vascular en nuestro centro durante 2005-2006. Analizamos datos clínicos, parámetros serológicos (creatinina, colesterol total, colesterol unido a lipoproteínas de baja densidad [colesterol LDL], colesterol unido a lipoproteínas de alta densidad [colesterol HDL], apolipoproteína A1, apolipoproteína B100, lipoproteína(a), homocisteína, proteína C reactiva, velocidad de sedimentación globular [VSG], fibrinógeno), eventos cardiovasculares y mortalidad durante el seguimiento a 1-3 años. Resultados:Incluimos 162 pacientes, de los que 143 (88,3%) eran varones. La edad media (DE) fue de 66 (10,4) años (extremos 41-86), 76 (46,9%) eran fumadores activos, 96 (59,3%) hipertensos, 56 (34,6%) diabéticos y 129 (79,6%) hipercolesterolémicos. Registramos 16 (9,9%) eventos coronarios/cerebrovasculares, 18 (11,1%) eventos vasculares en extremidades inferiores y 9 (5,9%) muertes tardías durante el seguimiento (media de 18,2 [8] meses). La hipertensión arterial fue el único predictor de eventos coronarios o cerebrovasculares (p=0,013); la cardiopatía y el colesterol HDL&lt;45mg/dL se asociaron de forma independiente a eventos vasculares de extremidades inferiores (p=0,021 y 0,049), y la VSG&gt;20mm/h a mortalidad (p=0,008). Conclusiones: Las cifras reducidas de colesterol HDL y elevadas de VSG han resultado factores de riesgo independientes para eventos vasculares periféricos y mortalidad a corto plazo (AU)</dc:description>
<dc:source>Med. clín (Ed. impr.);136(6): 244-247, mar. 2011. tab</dc:source>
<dc:identifier>ibc-87128</dc:identifier>
<dc:title xml:lang="es">Valor pronóstico de marcadores inflamatorios y perfil lipídico en pacientes con claudicación intermitente. Estudio piloto</dc:title>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d8230^s22062</dc:subject>
<dc:subject>^d3421^s22002</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30252^s22062</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d7547^s22032</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d1163^s22080</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d22124^s22002</dc:subject>
<dc:subject>^d7426^s22032</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d52261^s22062</dc:subject>
<dc:subject>^d32175^s22002</dc:subject>
<dc:subject>^d8250^s22062</dc:subject>
<dc:subject>^d8252^s22062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201103</dc:date>
</metadata>
</record>
</ibecs-document>
